← Evidence map

ArticleMolecular neurobiology2026

LXR Pathway Activation by T0901317: A Novel Potential Experimental Strategy for ALS-Related Cognitive and Motor Impairments via Suppression of Necroptosis-associated RIPK1/RIPK3/MLKL Markers.

Xiaojie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

LXR Pathway Activation by T0901317: A Novel Potential Experimental Strategy for ALS-Related Cognitive and Motor Impairments via Suppression of Necroptosis-associated RIPK1/RIPK3/MLKL Markers. | OpenQuestion